share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144:拟议出售证券
美股SEC公告 ·  2024/09/04 01:41

Moomoo AI 已提取核心信息

Howard G. Welgus, a Director at Arcutis Biotherapeutics, Inc., is set to sell 10,000 shares of common stock on 09/03/2024, with an aggregate market value of $107,695. The shares were originally acquired on 06/04/2018 through a stock option exercise from Arcutis Biotherapeutics Inc, and were paid for in cash. This planned sale follows a three-month period where Welgus sold a total of 30,000 shares, grossing $271,936. The notice for the upcoming sale was filed on the same date as the planned sale, with the instruction for this transaction given on 03/05/2024.
Howard G. Welgus, a Director at Arcutis Biotherapeutics, Inc., is set to sell 10,000 shares of common stock on 09/03/2024, with an aggregate market value of $107,695. The shares were originally acquired on 06/04/2018 through a stock option exercise from Arcutis Biotherapeutics Inc, and were paid for in cash. This planned sale follows a three-month period where Welgus sold a total of 30,000 shares, grossing $271,936. The notice for the upcoming sale was filed on the same date as the planned sale, with the instruction for this transaction given on 03/05/2024.
Arcutis Biotherapeutics公司的董事Howard G. Welgus计划于2024年09月03日卖出10,000股普通股,合计市值为$107,695。这些股票最初是通过从Arcutis Biotherapeutics Inc进行股票期权行权于2018年06月04日购买的,且是用现金支付的。这次计划的出售是在Welgus连续三个月出售了总共30,000股股票、获得$271,936的情况下进行的。计划销售的通知是在同一天提交的,该交易的指示日期为2024年03月05日。
Arcutis Biotherapeutics公司的董事Howard G. Welgus计划于2024年09月03日卖出10,000股普通股,合计市值为$107,695。这些股票最初是通过从Arcutis Biotherapeutics Inc进行股票期权行权于2018年06月04日购买的,且是用现金支付的。这次计划的出售是在Welgus连续三个月出售了总共30,000股股票、获得$271,936的情况下进行的。计划销售的通知是在同一天提交的,该交易的指示日期为2024年03月05日。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息